CME Group EPS (Diluted) decreased by 1.9% to $3.18 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.4%, from $2.62 to $3.18. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 11.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.42 | $2.58 | $1.69 | $1.95 | $1.82 | $1.87 | $1.76 | $2.43 | $2.14 | $2.06 | $2.23 | $2.35 | $2.42 | $2.50 | $2.40 | $2.62 | $2.81 | $2.49 | $3.24 | $3.18 |
| QoQ Change | — | +81.7% | -34.5% | +15.4% | -6.7% | +2.7% | -5.9% | +38.1% | -11.9% | -3.7% | +8.3% | +5.4% | +3.0% | +3.3% | -4.0% | +9.2% | +7.3% | -11.4% | +30.1% | -1.9% |
| YoY Change | — | — | — | — | +28.2% | -27.5% | +4.1% | +24.6% | +17.6% | +10.2% | +26.7% | -3.3% | +13.1% | +21.4% | +7.6% | +11.5% | +16.1% | -0.4% | +35.0% | +21.4% |